Modulation of Neurotransmission by Cannabinoids in the Basal Ganglia

This publication has 57 references indexed in Scilit:

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
  Published by Wiley ,2001
• Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain
  Life Sciences, 1996
• Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1, receptor ligand
  Life Sciences, 1996
• Enzymatic Synthesis of Anandamide, an Endogenous Cannabinoid Receptor Ligand, through N-Acylphosphatidylethanolamine Pathway in Testis: Involvement of Ca2+-Dependent Transacylase and Phosphodiesterase Activities
  Biochemical and Biophysical Research Communications, 1996
• The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway
  Brain Research, 1995
• Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids
  Neuropharmacology, 1991
• Neurotransmitters and neuromodulators in the basal ganglia
  Trends in Neurosciences, 1990
• The functional anatomy of basal ganglia disorders
  Trends in Neurosciences, 1989
• Treatment of Human Spasticity with Δ⁹‐Tetrahydrocannabinol
  The Journal of Clinical Pharmacology, 1981
• Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
  Journal of the American Chemical Society, 1964